Brief: Lee's Pharmaceutical Holdings Sells 45.5 Pct Stake In China Ophthalmology Focus
23/05/2019 15:21
May 23 (Reuters) - Lee's Pharmaceutical Holdings Ltd
0950.HK :
* COMPANY AGREED TO ISSUE AND SELL AGGREGATE OF 334,280
SERIES A
PREFERRED SHARES AT CONSIDERATION OF US$50 MILLION
* PREFERRED SHARES TO BE ISSUED REPRESENT ABOUT 45.525% OF
EQUITY
SHARE CAPITAL OF CHINA OPHTHALMOLOGY FOCUS LTD
Source text for Eikon: urn:newsml:reuters.com:*:nHKS5c3NHh
Further company coverage: 0950.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lees Pharmaceutical Holdings
See all newsBrief: Lee's Pharmaceutical Announces Share Repurchase Program Under Repurchase Mandate
Brief: Lee's Pharmaceutical To Receive Funding From Gates Foundation For Synthetic Surfactant Project
Brief: Lee's Pharmaceutical Says Zhaoke Hefei To Contribute Rmb25 Million To Partnership Fund
Brief: Lee's Pharmaceutical Declares Final Dividend Of HK2.3 Cents Per Share
Brief: Lee's Pharmaceutical Reports Approval Of Intrarosa By NMPA